Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
paracetamol + pseudoephedrine + triprolidine
- Development stage
- Unknown
- Lead developer
- LIFEPharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Coldifed-P is a combination pharmaceutical product developed and manufactured by LIFEPharma. It is indicated for the symptomatic relief of the common cold, cough, and flu-like symptoms. The formulation typically contains paracetamol (an analgesic and antipyretic), pseudoephedrine (a nasal decongestant), and triprolidine (an antihistamine). Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system. Pseudoephedrine acts as a sympathomimetic agent on alpha-adrenergic receptors to reduce nasal congestion. Triprolidine is a first-generation H1-receptor antagonist that reduces allergic symptoms such as sneezing and runny nose.
- Brand names
- Coldifed-P
- Other names
- Coldifed-P
02
Targets
HTR7 (5-hydroxytryptamine receptor 7)ADRA2A (α2A)CNR1 (Cannabinoid receptor 1)HRH1 (Histamine H1 Receptor)NET (Norepinephrine Transporter)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)ADRA1A (α1A)
Beyond the preview
Go deeper on paracetamol + pseudoephedrine + triprolidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on paracetamol + pseudoephedrine + triprolidine.